Smad-dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF-β

被引:151
作者
Takekawa, M
Tatebayashi, K
Itoh, F
Adachi, M
Imai, K
Saito, H
机构
[1] Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Minato Ku, Tokyo 1088639, Japan
[2] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan
[3] Sapporo Med Univ, Sch Med, Dept Internal Med 1, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
关键词
GADD45; beta; p38; Smad; TGF-beta; thrombospondin-1;
D O I
10.1093/emboj/cdf643
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor-beta (TGF-beta), when bound to its specific receptor, activates the transcription factor Smad by phosphorylation. TGF-beta also activates the p38 MAPK pathway, but there seem to be disparate mechanisms for the early p38 activation and delayed p38 activation. In this report, we demonstrate that Smad-dependent expression of GADD45beta is responsible for the delayed activation of p38 by TGF-beta. The GADD45beta protein binds and activates MTK1 (=MEKK4), which is a member of the MAPKKK family kinases and an upstream activator of the p38 MAPK cascade. Both TGF-beta-induced GADD45beta expression and the delayed p38 activation require functional Smad proteins. Antisense inhibition of GADD45beta expression suppresses the TGF-beta-induced delayed p38 activation, whereas overexpression of GADD45beta activates the p38 MAPK via MTK1. Expression of the angiogenesis inhibitor thrombospondin-1 (TSP-1) is induced by TGF-beta via Smad-dependent p38 activation. Thus TGF-beta-induced p38 activation, mediated by GADD45beta expression, may play an important role in the biological effects of TGF-beta.
引用
收藏
页码:6473 / 6482
页数:10
相关论文
共 49 条
[1]   The 18q21 region in colorectal and pancreatic cancer:: independent loss of DCC and DPC4 expression [J].
Barberá, VM ;
Martín, M ;
Mariñoso, L ;
Munné, A ;
Carrato, A ;
Real, FX ;
Fabre, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (02) :283-296
[2]   Thrombospondins as matricellular modulators of cell function [J].
Bornstein, P .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (08) :929-934
[3]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[4]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[5]   TGF-beta receptor signaling [J].
Derynck, R ;
Feng, XH .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1333 (02) :F105-F150
[6]   INCREASED TUMORIGENICITY IN THE HUMAN PANCREATIC-CELL LINE MIA PACA-2 IS ASSOCIATED WITH AN ABERRANT REGULATION OF AN IGF-1 AUTOCRINE LOOP AND LACK OF EXPRESSION OF THE TGF-BETA TYPE RII RECEPTOR [J].
FREEMAN, JW ;
MATTINGLY, CA ;
STRODEL, WE .
JOURNAL OF CELLULAR PHYSIOLOGY, 1995, 165 (01) :155-163
[7]   Roles of bone morphogenetic protein type I receptors and smad proteins in osteoblast and chondroblast differentiation [J].
Fujii, M ;
Takeda, K ;
Imamura, T ;
Aoki, H ;
Sampath, TK ;
Enomoto, S ;
Kawabata, M ;
Kato, M ;
Ichijo, H ;
Miyazono, K .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (11) :3801-3813
[8]   TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation [J].
Giehl, K ;
Seidel, B ;
Gierschik, P ;
Adler, G ;
Menke, A .
ONCOGENE, 2000, 19 (39) :4531-4541
[9]  
Grau AM, 1997, CANCER RES, V57, P3929
[10]   DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [J].
Hahn, SA ;
Schutte, M ;
Hoque, ATMS ;
Moskaluk, CA ;
daCosta, LT ;
Rozenblum, E ;
Weinstein, CL ;
Fischer, A ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
SCIENCE, 1996, 271 (5247) :350-353